Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great video about Vbloc:
http://skyridgemedcenter.com/service/bariatric-surgery
You are 1 day too early.
So if I am understanding this correctly, Ardsley Partners was the one dumping. They owned 9.8%, which is around what, 6.7M shares, and now own 0 shares.
http://www.insidercow.com/institution/acquirer.jsp?acquirer=0000900529&company=ARDSLEY%20ADVISORY%20PARTNERS
Who is crushing this and why? I just don't understand. I really wish I had sold out on aprroval, but I thought it would hold, not slide. I hate this stock and want nothing to do with it any more.
I also thought it would go up after FDA approval. I guess I really don't understand these biomedpharmwhatever stocks. Once I can free my money from this stock, I am done with these stocks! I really wish I had sold when it shot up. I knew it would drop a little from the high as a result of profit takers, but I never thought it would end the week lower than the pre FDA approval price.
Some good byuing today
Big buy right there. Seems like something brewing.
Nevermind, looks like someone dumped at the very last minute.
Good rebound to close the day.
This is holding up pretty well against the profit takers. Should move up once they are cleared out.
Strong close and after hours has a bid at $1.01.
ImmunoCellular Therapeutics receives positive regulatory feedback from European Medicines Agency on advancing ICT-107 to Phase III Program
Co announced that the European Medicines Agency (EMA) has provided scientific advice supportive of advancing ICT-107 to a registrational phase III program in patients with newly diagnosed glioblastoma (GBM).
The EMA guidance is consistent with the positive feedback the Company received from the US FDA relative to the scope, design and endpoints of the program and the inclusion of patients based on HLA and MGMT status.?ImmunoCellular intends to finalize the design of the phase III program, ensuring harmony between US and EU trial protocols, with the goal of being in position to initiate the phase III program.?The co now is evaluating options for funding the phase III program, which may enable the initiation in 2015.
Yes, it could test $2 by end of week.
Thats strange, what broker?
Adamis Pharmaceuticals Corporation (Nasdaq:ADMP) is scheduled to present a company overview at two upcoming conferences:
Event: 7th Annual LD Micro Conference Date: Wednesday, December 3, 2014 Time: 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) Location: Luxe Hotel in Los Angeles, California
Event: 25th Annual Oppenheimer Healthcare Conference Date: Wednesday, December 10, 2014 Time: 3:20 p.m. Eastern Time (12:20 p.m. Pacific Time) Location: Crowne Plaza Hotel, New York, New York
Good day, whats driving this? Hopefully insider buying. This should move higher the closer we get to FDA decision. Could be big gains here.
This thing pops and there is very little chatter today...whats up with that.
Yep, I'm thinking it could hit $1.50 this week, maybe more.
Good strong ending! I like where this is going. We could potentially see some big gains here as we get closer to FDA decision.
"According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Joseph Pantginis has a total average return of -4.9% and a 45.6% success rate. Pantginis has a -43.8% average return when recommending IMUC, and is ranked #3285 out of 3367 analysts."
Still very confident in a positive FDA approval by end of year! Things could get interesting very quickly!
Is this thing ever going to overcome the $1.14s? The more it trades the more $1.14s show up!
This has pulled back more than I thought it would. This market is tough to predict.
That is why I got out today with my 1% gain. It keeps getting pulled intra day below that .55 mark and I was worried it was going to drop back into the .40's in the next couple weeks. I'll still watch, but the market does not make me very confident in anything right now.
Glad I doubled down at $5.00. I wish I had more to sink into this when it was in that $5 range, but I'm tied up in GTXI and ETRM.
You must be looking at DGRI? It was about dead at .0001 and is at .0018 today.
We can dream that TIVU does the same, but it's only a dream.
Well, there goes the bid. Bid/Ask are now both back at .0001.
Things are starting to heat up, could be an interesting close.
964K on the bid at .55! what is that all about? Is this thing is about to blow!
4 Stocks Under $10 Triggering Breakouts
Guanwei Recycling (GPRC_) engages in the manufacture and distribution of low-density polyethylene and other recycled plastics products primarily in the People's Republic of China and internationally. This stock closed up 6.7% to $3.02 in Thursday's trading session.
Thursday's Range: $2.85-$3.19
52-Week Range: $1.14-$3.60
Thursday's Volume: 346,000
Three-Month Average Volume: 58,952
From a technical perspective, GPRC spiked sharply higher here right above its 50-day moving average of $2.76 with strong upside volume. This move pushed shares of GPRC into breakout territory, since the stock took out some near-term overhead resistance at $2.86. Shares of GPRC are now quickly moving within range of triggering an even bigger breakout trade. That trade will hit if GPRC manages to take out Thursday's high of $3.19 to more resistance at $3.37 and then once it clears its 52-week high at $3.60 with strong volume.
Traders should now look for long-biased trades in GPRC as long as its trending above Thursday's low of $2.85 or above its 50-day at $2.76 and then once it sustains a move or close above those breakout levels with volume that hits near or above 58,952 shares. If that breakout gets underway soon, then GPRC will set up to re-test or possibly take out its next major overhead resistance levels at $3.90 to $4.20, or even $4.50.
http://www.thestreet.com/story/12521072/2/4-stocks-under-10-triggering-breakouts.html
Did anyone ever post about this litigation?
http://www.sec.gov/litigation/complaints/2012/comp-pr2012-257.pdf
So it looks like this guy submitted 12 Attorney Opinion Letters with a forged signature for Tivus.
The Suspension of DTC Services happened several weeks after the filing.
Response from Scottrade:
I understand you would like to know what is occurring with the security (TIVU).
Please note that Scottrade is not accepting any orders (buy or sell) for (TIVU).
This trading restriction is due to the "global lock" that has been placed on the security by the Depository Trust & Clearing Corporation (DTCC). DTCC, through its subsidiaries, acts as a centralized clearinghouse, providing clearing and settlement services for U.S. Securities firms.
The global lock simply means that DTCC has suspended their trade settlement services for the particular security; therefore, we cannot settle trades or transfer incoming or outgoing positions. We will not accept orders for (TIVU) until the DTCC global lock has been lifted. We have no way of estimating when that might occur.
As we have modified the symbol on our system with the addition of parenthesis to prevent orders from being submitted, price changes will not be reflected as the modified symbol is not recognized by our quote data system.
I contacted etrade, they responded:
Just looking at the OTC markets site, this company may not be making material information publicly available. This means that if you are in possession of nonpublic material, buying or selling this security may constitute trading "on the basis of" material nonpublic information prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder.
This would be why we still have this security restricted.
I just wish we had some update about what is going on. Yesterday was strange and the fact that some people said they could trade it again. The big question is who is buying the shares that those people are able to sell.
There are just too many unanswered questions right now.
Scottrade is now showing the value for TIVU shares @.0001 in my account.
Still cannot trade.
Some good action today
Thanks Bob!
I am a newer investor, less than 2 years and active only as time permits. I appreciate being able to learn from you and others. I lost about 80% of my initial investment early on, since I didn't know what I was doing (doing better, but still learning). I have earned back about 25% of that.
In on MSTX at $.78
Still holding OIBR (non bio)
Oi SA Research Report
On October 2, 2013, Oi SA (Oi), along with Portugal Telecom SGPS, S.A., announced the execution of a Memorandum of Understanding (MoU) for the merger of the activities of both the Companies. The Company informed that Oi, Portugal Telecom SGPS S.A., AG Telecom Participações S.A., LF Tel SA, PASA Participações S.A., EDSP75 Participações S.A., Bratel Brasil S.A., and also certain shareholders of Portugal Telecom, in particular, Avistar, SGPS, S.A. and Nivalis Holding B.V have entered into a MoU which establishes the basis and principles that will govern the negotiations of a potential transaction involving Portugal Telecom, Oi and some of their controlling shareholders to form a combined entity, which will unite the shareholders of Oi, Portugal Telecom and Telemar Participações S.A. ("TelPart") and combine the activities and businesses developed by Oi in Brazil and Portugal Telecom in Portugal and Africa. The Full Research Report on Oi SA - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.analystscorner.com/r/full_research_report/744d_OIBR]
5 Stocks Under $10 in Breakout Territory
BY Roberto Pedone | 09/18/13 - 07:34 AM EDT Stock quotes in this article: GCA, MCP, KNDI, GFA, OIBR Tweet Comment Link
Find out if (GCA) is in Cramer's Portfolio.Oi
Oi (OIBR) provides telecommunication services in Brazil. This stock closed up 1.6% to $1.87 in Tuesday's trading session.
Tuesday's Range: $1.83-$1.89
52-Week Range: $1.42-$4.51
Tuesday's Volume: 2.61 million
Three-Month Average Volume: 4.32 million
>>5 Stocks Ready for Breakouts
From a technical perspective, OIBR rose modestly higher here right above its 50-day moving average of $1.72 with lighter-than-average volume. This stock has been uptrending strong for the last few weeks, with shares moving higher from its low of $1.42 to its intraday high of $1.89. During that move, shares of OIBR have been consistently making higher lows and higher highs, which is bullish technical price action. That move is quickly pushing shares of OIBR within range of triggering a near-term breakout trade. That trade will hit if OIBR manages to take out some near-term overhead resistance levels at $1.89 to $2.04 with high volume.
Traders should now look for long-biased trades in OIBR as long as it's trending above its 50-day at $1.72 or above more support at $1.60 and then once it sustains a move or close above those breakout levels with volume that's near or above 4.32 million shares. If that breakout hits soon, then OIBR will set up to re-test or possibly take out its next major overhead resistance levels at $2.25 to $2.29. Any high-volume move above those levels will then give OIBR a chance to tag $2.50 to $2.75.
Am I the only one seeing 20M in volume today? What is up with that?